253 related articles for article (PubMed ID: 28166796)
1. Coenzyme Q
de la Mata M; Cotán D; Oropesa-Ávila M; Villanueva-Paz M; de Lavera I; Álvarez-Córdoba M; Luzón-Hidalgo R; Suárez-Rivero JM; Tiscornia G; Sánchez-Alcázar JA
Orphanet J Rare Dis; 2017 Feb; 12(1):23. PubMed ID: 28166796
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease.
de la Mata M; Cotán D; Oropesa-Ávila M; Garrido-Maraver J; Cordero MD; Villanueva Paz M; Delgado Pavón A; Alcocer-Gómez E; de Lavera I; Ybot-González P; Paula Zaderenko A; Ortiz Mellet C; García Fernández JM; Sánchez-Alcázar JA
Sci Rep; 2015 Jun; 5():10903. PubMed ID: 26045184
[TBL] [Abstract][Full Text] [Related]
3. Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease.
Hamler R; Brignol N; Clark SW; Morrison S; Dungan LB; Chang HH; Khanna R; Frascella M; Valenzano KJ; Benjamin ER; Boyd RE
Anal Chem; 2017 Aug; 89(16):8288-8295. PubMed ID: 28686011
[TBL] [Abstract][Full Text] [Related]
4. In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.
Prence EM; Chaturvedi P; Newburg DS
J Neurosci Res; 1996 Feb; 43(3):365-71. PubMed ID: 8714525
[TBL] [Abstract][Full Text] [Related]
5. Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.
Naito Y; Sakamoto S; Kojima T; Homma M; Tanaka M; Matsui H
SLAS Discov; 2023 Oct; 28(7):344-349. PubMed ID: 37369311
[TBL] [Abstract][Full Text] [Related]
6. Glucosylceramide modulates endolysosomal pH in Gaucher disease.
Sillence DJ
Mol Genet Metab; 2013 Jun; 109(2):194-200. PubMed ID: 23628459
[TBL] [Abstract][Full Text] [Related]
7. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.
Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L
J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774
[TBL] [Abstract][Full Text] [Related]
8. GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice.
van der Lienden MJC; Aten J; Marques ARA; Waas ISE; Larsen PWB; Claessen N; van der Wel NN; Ottenhoff R; van Eijk M; Aerts JMFG
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802460
[TBL] [Abstract][Full Text] [Related]
9. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
[TBL] [Abstract][Full Text] [Related]
10. Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs.
Aflaki E; Stubblefield BK; Maniwang E; Lopez G; Moaven N; Goldin E; Marugan J; Patnaik S; Dutra A; Southall N; Zheng W; Tayebi N; Sidransky E
Sci Transl Med; 2014 Jun; 6(240):240ra73. PubMed ID: 24920659
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages.
Aflaki E; Moaven N; Borger DK; Lopez G; Westbroek W; Chae JJ; Marugan J; Patnaik S; Maniwang E; Gonzalez AN; Sidransky E
Aging Cell; 2016 Feb; 15(1):77-88. PubMed ID: 26486234
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cellular cobalamin metabolism in Gaucher disease.
Basgalupp SP; Siebert M; Ferreira C; Behringer S; Spiekerkoetter U; Hannibal L; Schwartz IVD
BMC Med Genet; 2020 Jan; 21(1):12. PubMed ID: 31931749
[TBL] [Abstract][Full Text] [Related]
13. Animal Models for the Study of Gaucher Disease.
Cabasso O; Kuppuramalingam A; Lelieveld L; Van der Lienden M; Boot R; Aerts JM; Horowitz M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003227
[TBL] [Abstract][Full Text] [Related]
14. Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells.
Awad O; Sarkar C; Panicker LM; Miller D; Zeng X; Sgambato JA; Lipinski MM; Feldman RA
Hum Mol Genet; 2015 Oct; 24(20):5775-88. PubMed ID: 26220978
[TBL] [Abstract][Full Text] [Related]
15. Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism.
Kopytova AE; Rychkov GN; Nikolaev MA; Baydakova GV; Cheblokov AA; Senkevich KA; Bogdanova DA; Bolshakova OI; Miliukhina IV; Bezrukikh VA; Salogub GN; Sarantseva SV; Usenko TC; Zakharova EY; Emelyanov AK; Pchelina SN
Parkinsonism Relat Disord; 2021 Mar; 84():112-121. PubMed ID: 33609962
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
Barnes S; Xu YH; Zhang W; Liou B; Setchell KD; Bao L; Grabowski GA; Sun Y
PLoS One; 2014; 9(12):e116023. PubMed ID: 25551612
[TBL] [Abstract][Full Text] [Related]
17. Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.
Newburg DS; Shea TB; Yatziv S; Raghavan SS; McCluer RH
Exp Mol Pathol; 1988 Jun; 48(3):317-23. PubMed ID: 3371456
[TBL] [Abstract][Full Text] [Related]
18. Interaction with ERp57 is required for progranulin protection against Type 2 Gaucher disease.
Liu Y; Zhao X; Jian J; Hasan S; Liu C
Biosci Trends; 2023 May; 17(2):126-135. PubMed ID: 36889696
[TBL] [Abstract][Full Text] [Related]
19. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
[TBL] [Abstract][Full Text] [Related]
20. Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.
Yang NY; Lee YN; Lee HJ; Kim YS; Lee SJ
Biol Chem; 2013 Jul; 394(7):807-18. PubMed ID: 23435096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
